A novel HER-2-specific exosome-targeted T cell-based vaccine: immunotherapy of established lung metastasis in transgenic HLA-A2/HER-2 mice

被引：0

作者：

Wang, Lu ^{[1
]}

Xie, Yufeng ^{[1
]}

Wei, Yangdou ^{[1
]}

Mulligan, Sean ^{[1
]}

Xiang, Jim ^{[1
]}

机构：

[1] Univ Saskatchewan, Saskatoon, SK, Canada

来源：

JOURNAL OF IMMUNOLOGY | 2011年 / 186卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

155.37

引用

页数：2

共 50 条

[41] Direct measurement of peptide specific CD8+ T cells using HLA-A2:: Ig dimer for monitoring the in vivo immune response to a Her2/neu vaccine in breast and prostate cancer patients
Woll, MM
Fisher, CM
Ryan, GB
Ponniah, S
Peoples, GE
ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (01) : S38 - S38
[42] Characterization of HLA-A2-restricted HPV-16 E7-specific CD8+ T-cell immune responses induced by DNA vaccines in HLA-A2 transgenic mice
Peng, S
Trimble, C
He, L
Tsai, YC
Lin, CT
Boyd, DAK
Pardoll, D
Hung, CF
Wu, TC
GENE THERAPY, 2006, 13 (01) : 67 - 77
[43] Non-immunodominant CD8+ T-cell responses can be harnessed to mount antitumor immunity in the tolerant HER-2/neu transgenic mice
Uram, Jennifer
Black, Chelsea
Flynn, Emilee
Huang, Lanqing
Armstrong, Todd
Jaffee, Elizabeth
CANCER RESEARCH, 2009, 69
[44] Antigen specific elimination of established tumor metastases in mice following adoptive immunotherapy with genetically modified murine T-cells expressing a chimeric T-cell receptor (chTCR) specific for p185HER2.
Yang, JM
Friedman, MS
Fuller, J
Braun, T
Eshhar, Z
Mule, JJ
McDonagh, KT
BLOOD, 2000, 96 (11) : 551A - +
[45] Direct Measurement of Peptide-Specific CD8+ T Cells Using HLA-A2:Ig Dimer for Monitoring the In Vivo Immune Response to a HER2/neu Vaccine in Breast and Prostate Cancer Patients
Michael M. Woll
Christine M. Fisher
Gayle B. Ryan
Jennifer M. Gurney
Catherine E. Storrer
Constantin G. Ioannides
Craig D. Shriver
Judd W. Moul
David G. Mcleod
Sathibalan Ponniah
George E. Peoples
Journal of Clinical Immunology, 2004, 24 : 449 - 461
[46] Direct measurement of peptide-specific CD8C T cells using HLA-A2:Ig dimer for monitoring the in vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients
Woll, MM
Fisher, CM
Ryan, GB
Gurney, JM
Storrer, CE
Ioannides, CG
Shriver, CD
Moul, JW
Mcleod, DG
Ponniah, S
Peoples, GE
JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (04) : 449 - 461
[47] H3.3K27M mutation-derived novel neoantigen - characterization of the HLA-A2-binding epitope and a specific T cell receptor for development of T cell-based immunotherapy
Chheda, Zinal
Kohanbash, Gary
Okada, Kaori
Jahan, Naznin
Sidney, John
Pecoraro, Matteo
Carrera, Diego
Shrivastav, Shruti
Liu, Shuming
Mueller, Sabine
Pollack, Ian
Rajalingam, Raja
Carcaboso, Angel
Mann, Matthias
Sette, Alessandro
Hou, Yafei
Okada, Hideho
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[48] H3.3K27M MUTATION-DERIVED NOVEL NEOANTIGEN - CHARACTERIZATION OF THE HLA-A2-BINDING EPITOPE AND A SPECIFIC T CELL RECEPTOR FOR DEVELOPMENT OF T CELL-BASED IMMUNOTHERAPY
Chheda, Zinal
Kohanbash, Gary
Okada, Kaori
Jahan, Naznin
Sidney, John
Pecoraro, Matteo
Carrera, Diego
Shrivastav, Shruti
Liu, Shuming
Downey, Kira
Chuntova, Pavlina
Watchmaker, Payal
Mueller, Sabine
Pollack, Ian
Rajalingam, Raja
Montero Carcaboso, Angel
Mann, Matthias
Sette, Alessandro
Hou, Yafei
Okada, Hideho
NEURO-ONCOLOGY, 2017, 19 : 121 - 121
[49] Contrasting Epstein-Barr virus-specific cytotoxic T cell responses to HLA A2-restricted epitopes in humans and HLA transgenic mice: implications for vaccine design
Bharadwaj, M
Sherrit, M
Khanna, R
Moss, DJ
VACCINE, 2001, 19 (27) : 3769 - 3777
[50] A CD80-transfected human breast cancer cell variant induces HER-2/neu–specific T cells in HLA-A*02–matched situations in vitro as well as in vivo
Brigitte Gückel
Susanne Stumm
Christine Rentzsch
Alexander Marmé
Geeske Mannhardt
Diethelm Wallwiener
Cancer Immunology, Immunotherapy, 2005, 54 : 129 - 140

← 1 2 3 4 5 →